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The lymphoid enhancer factor (Lef-1) belongs to the
nuclear transducers of canonical Wnt-signalling in embry-
ogenesis and cancer. Lef-1 acts, in cooperation with beta-
catenin, as a context-dependent transcriptional activator
or repressor thereby influencing multiple cellular func-
tions such as proliferation, differentiation and migration.
Here we report an increased Lef-1 expression in human
pancreatic cancer, which correlates with advanced tumour
stages. As demonstrated by RT-PCR analysis, pancreatic
carcinoma exhibit two different transcripts present in pan-
creatic carcinomas. One transcript was identified as the
full length Lef-1 (Lef-1 FL), whereas the second, shorter
transcript, lacked exon VI (Lef-1 exon VI) compared to the
published sequence. Comparative analysis of these two
Lef-1 variants revealed different cellular effects after tran-
sient expression in pancreatic carcinoma cells. Forced
expression of Lef-1 exon VI in pancreatic carcinoma cells
inhibited E-cadherin expression and resulted in reduced
cellular aggregation and increased cell migration com-
pared to cells expressing full length Lef-1. Expression of
Lef-1 FL, but not the newly identified Lef-1 exon VI,
induced expression of the cell cycle regulating proteins c-
myc and cyclin D1 and resulted in enhanced cell prolifer-
ation.
Thus, our findings implicate that expression of alterna-
tively spliced isoforms of Lef-1 are involved in the deter-
mination of proliferative or migratory characteristics of
pancreatic carcinoma cells.
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